Article
Early reduction in PD-L1 expression predicts faster treatment response in human cutaneous leishmaniasis
2020-02-24
Abstract excerpt
Cutaneous leishmaniasis (CL) is a chronic skin disease caused by Leishmania parasites and in Sri Lanka, CL is caused by L. donovani. Pentavalent antimonials (e.g. sodium stibogluconate; SSG) are first line drugs for CL, despite protracted and painful treatment regimens. Data from animal models indicate that the effectiveness of SSG requires drug-immune synergy, but mechanistic insight from patients is lacking. W...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5a6d77e3-de72-58ae-b692-3f0e00a3b133
- DOI
- 10.1101/2020.02.21.959528
